Immunocore Holdings plc
Commercial-stage TCR-bispecific biotech with KIMMTRAK and multiple late-stage melanoma programs.
Oncology, infectious & autoimmune disease · TCR bispecific ImmTAX therapies · Commercial + Phase 3
Commercial-stage TCR-bispecific biotech with KIMMTRAK and multiple late-stage melanoma programs.
Oncology, infectious & autoimmune disease · TCR bispecific ImmTAX therapies · Commercial + Phase 3